Literature DB >> 31542480

Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension.

Ting Liu1, Xiao-Zhou Zou2, Ning Huang1, Xiao-Yue Ge1, Mao-Zhong Yao1, Hong Liu1, Zheng Zhang3, Chang-Ping Hu4.   

Abstract

Pulmonary arterial remodeling is a crucial cause of increased pulmonary artery pressure during pulmonary hypertension (PH). Recently, growing evidence has upheld the contribution of endothelial-mesenchymal transition (EndMT) to pulmonary arterial remodeling, but the underlying mechanisms remain largely unaddressed. miR-204 has been implicated in PH, being anti-proliferative and pro-apoptotic in pulmonary artery smooth muscles cells (PASMCs), but its role in EndMT is still unknown. Here we found that miR-204 was down-regulated by hypoxia in rat pulmonary arterial intima and human pulmonary artery endothelial cells (HPAECs), and its further down-regulation by using miR-204 inhibitor suppressed hypoxia-induced EndMT. Moreover, autophagy, evoked by hypoxia in rat pulmonary arterial intima and HPAECs, suppressed hypoxia-induced EndMT via p62-dependent degradation of Snail and Twist. Additionally, autophagy was regulated by miR-204 targeting ATG7. While down-regulation of miR-204 in PASMCs reportedly promoted monocrotaline-induced pulmonary arterial hypertension via increased cell proliferation, our data suggested an important, albeit dichotomous, role of miR-204 down-regulation in endothelial cells in the process of EndMT that it attenuated EndMT by enhancing autophagy, thereby ameliorating hypoxia-induced PH to some extent.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  ATG7; Autophagy; Endothelial-mesenchymal transition; Pulmonary hypertension; miR-204; p62

Mesh:

Substances:

Year:  2019        PMID: 31542480     DOI: 10.1016/j.ejphar.2019.172673

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Serum miRNA-204-5p as a potential non-invasive biomarker for the diagnosis of endometrial cancer with sentinel lymph node mapping.

Authors:  Cailiang Wu; Xuexin Zhou; Jiayong Li; Ruiying Xiao; Haomin Xin; Lei Dai; Yaping Zhu; Wei Bao
Journal:  Oncol Lett       Date:  2022-06-07       Impact factor: 3.111

Review 2.  Endothelial-to-mesenchymal transition in systemic sclerosis.

Authors:  P Cipriani; R Giacomelli; P Di Benedetto; P Ruscitti; O Berardicurti; M Vomero; L Navarini; V Dolo
Journal:  Clin Exp Immunol       Date:  2021-04-18       Impact factor: 5.732

3.  Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients.

Authors:  Raquel Díaz; Pilar Sandoval; Raul R Rodrigues-Diez; Gloria Del Peso; José A Jiménez-Heffernan; Ricardo Ramos-Ruíz; Carlos Llorens; Gustavo Laham; Mabel Alvarez-Quiroga; Manuel López-Cabrera; Marta Ruiz-Ortega; María A Bajo; Rafael Selgas
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 4.  Non-Coding RNA Networks in Pulmonary Hypertension.

Authors:  Hongbin Zang; Qiongyu Zhang; Xiaodong Li
Journal:  Front Genet       Date:  2021-11-30       Impact factor: 4.599

5.  Expression of the microRNA-30 family in pulmonary arterial hypertension and the role of microRNA-30d-5p in the regulation of pulmonary arterial smooth muscle cell toxicity and apoptosis.

Authors:  Fan Hu; Hanmin Liu; Chuan Wang; Hanwen Li; Lina Qiao
Journal:  Exp Ther Med       Date:  2021-12-02       Impact factor: 2.447

6.  Decrease in LINC00963 attenuates the progression of pulmonary arterial hypertension via microRNA-328-3p/profilin 1 axis.

Authors:  Chengpeng Yang; Rong Rong; Yuze Li; Mingxun Cheng; Yanzhuo Luo
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 3.124

Review 7.  A promising field: regulating imbalance of EndMT in cardiovascular diseases.

Authors:  Kun Zhou; Kai-Jiang Tian; Bin-Jie Yan; Dan-Dan Gui; Wen Luo; Zhong Ren; Dang-Heng Wei; Lu-Shan Liu; Zhi-Sheng Jiang
Journal:  Cell Cycle       Date:  2021-07-16       Impact factor: 5.173

8.  Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.

Authors:  Martina Milani; Eleonora Mammarella; Simona Rossi; Chiara Miele; Serena Lattante; Mario Sabatelli; Mauro Cozzolino; Nadia D'Ambrosi; Savina Apolloni
Journal:  J Neuroinflammation       Date:  2021-06-12       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.